David Hung
CIK 1310880 · PRESIDENT AND CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDVN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1500 BROADWAY, SUITE 1401
NEW YORK, NY 10036
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 32,075 | $15.10 | $484.3K | -$63.7K | 11 | 2026-06-05 |
| NUVB | PRESIDENT AND CEO | — | $4.70 | — | $0 | 1 | 2026-03-03 |
| Nuvation Bio Inc. (NUVB.WS) Delisted | PRESIDENT AND CEO | 59,281,054 | $0.01 | $302.3K | $1.71M | 8 | 2025-06-18 |
| ESTA | Director | — | $63.52 | — | $0 | 2 | 2020-05-27 |
| MEDIVATION, INC. (MDVN) Delisted | President and CEO | 1,709,497 | — | — | -$73.04M | 50 | 2016-09-19 |
| Acer Therapeutics Inc. (OPXAW) Delisted | Director | 0 | — | — | -$123.4K | 9 | 2011-04-07 |
| Acer Therapeutics Inc. (OPXA) Delisted | Director | — | — | — | $0 | 1 | 2007-06-21 |
| MEDIVATION, INC. (MDV) Delisted | President and CEO | 1,710,711 | $18.05 | $30.88M | -$445.0K | 1 | 2007-03-20 |
Recent Filings · Page 7 of 9
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-12-13 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | +31,300 | $0 | EDGAR |
| 2011-04-07 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-02-24 | MEDIVATION, INC. (MDVN) Delisted | Disp (D) | −200,000 | -$3.39M | EDGAR |
| 2010-12-17 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | −33,333 | $0 | EDGAR |
| 2010-05-05 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-17 | MEDIVATION, INC. (MDVN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-12-08 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −25,000 | -$831.8K | EDGAR |
| 2009-09-11 | MEDIVATION, INC. (MDVN) Delisted | Sell (S) | −25,000 | -$646.0K | EDGAR |
| 2009-09-10 | Acer Therapeutics Inc. (OPXAW) Delisted | Sell (S) | −20,200 | -$84.4K | EDGAR |
| 2009-08-27 | Acer Therapeutics Inc. (OPXAW) Delisted | Mixed | −26,800 | -$39.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.